טוען...
Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis
BACKGROUND: Triple negative breast cancer (TNBC) is a highly heterogeneous and aggressive disease, and although no effective targeted therapies are available to date, about one-third of patients with TNBC achieve pathologic complete response (pCR) from standard-of-care anthracycline/taxane (ACT) che...
שמור ב:
| הוצא לאור ב: | PLoS Med |
|---|---|
| Main Authors: | , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Public Library of Science
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5154510/ https://ncbi.nlm.nih.gov/pubmed/27959926 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1002193 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|